Taking multiple infections of cells and recombination into account leads to small within-host effective-population-size estimates of HIV-1

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Balagam, Rajesh ^a   Singh, Vasantika ^a   Sagi, Aparna Raju ^a   Dixit, Narendra M ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EFFECTIVE POPULATION SIZE; EVOLUTION; GENETIC EPISTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PREDICTION; SIMULATION; STOCHASTIC MODEL; VIRUS GENOME; VIRUS MUTATION; VIRUS RECOMBINATION; CELL LINE; COMPUTER SIMULATION; GENETIC RECOMBINATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR EVOLUTION; MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CELL LINE; COMPUTER SIMULATION; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MUTATION; RECOMBINATION, GENETIC;

EID: 79251574660     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014531     Document Type: Article

References (69)

1. Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, et al. (1996) Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274: 985-989.
2. Telenti A, Goldstein DB (2006) Genomics meets HIV-1. Nat Rev Microbiol 4: 865-873.
3. Nijhuis M, Boucher CAB, Schipper P, Leitner T, Schuurman R, et al. (1998) Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proc Natl Acad Sci U S A 95: 14441-14446.
4. Telenti A, Carrington M (2008) Host factors associated with outcome from primary human immunodeficiency virus-1 infection. Curr Opin HIV AIDS 3: 28-35.
5. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, et al. (2005) The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 307: 1434-1440.
6. Charlesworth B (2009) Effective population size and patterns of molecular evolution and variation. Nat Rev Genet 10: 195-205.
7. Kouyos RD, Althaus CL, Bonhoeffer S (2006) Stochastic or deterministic: what is the effective population size of HIV-1? Trends Microbiol 14: 507-511.
8. Wright S (1931) Evolution in Mendelian populations. Genetics 16: 97-159.
9. Brown AL (1997) Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc Natl Acad Sci U S A 94: 1862-1865.
10. Rodrigo AG, Shpaer EG, Delwart EL, Iversen AKN, Gallo MV, et al. (1999) Coalescent estimates of HIV-1 generation time in vivo. Proc Natl Acad Sci U S A 96: 2187-2191.
11. Seo TK, Thorne JL, Hasegawa M, Kishino H (2002) Estimation of effective population size of HIV-1 within a host: A pseudomaximum-likelihood approach. Genetics 160: 1283-1293.
12. Achaz G, Palmer S, Kearney M, Maldarelli F, Mellors JW, et al. (2004) A robust measure of HIV-1 population turnover within chronically infected individuals. Mol Biol Evol 21: 1902-1912.
13. Shriner D, Shankarappa R, Jensen MA, Nickle DC, Mittler JE, et al. (2004) Influence of random genetic drift on human immunodeficiency virus type I env evolution during chronic infection. Genetics 166: 1155-1164.
14. Lemey P, Kosakovsky Pond SL, Drummond AJ, Pybus OG, Shapiro B, et al. (2007) Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol 3: e29.
15. Rouzine IM, Coffin JM (1999) Linkage disequilibrium test implies a large effective population number for HIV in vivo. Proc Natl Acad Sci U S A 96: 10758-10763.
16. Jung A, Maier R, Vartanian JP, Bocharov G, Jung V, et al. (2002) Multiply infected spleen cells in HIV patients. Nature 418: 144-144.
17. Levy DN, Aldrovandi GM, Kutsch O, Shaw GM (2004) Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci U S A 101: 4204-4209.
18. McCutchan FE (2006) Global epidemiology of HIV. J Med Virol 78: S7-S12.
19. Otto SP, Lenormand T (2002) Resolving the paradox of sex and recombination. Nat Rev Genet 3: 252-261.
20. Hartl DL, Clark AG (2007) Principles of Population Genetics. Sunderland: Sinauer Associates, Inc.
21. Kouyos RD, Silander OK, Bonhoeffer S (2007) Epistasis between deleterious mutations and the evolution of recombination. Trends Ecol Evol 22: 308-315.
22. Dixit NM (2008) Modelling HIV infection dynamics: The role of recombination in the development of drug resistance. Future HIV Ther 2: 375-388.
23. Boerlijst MC, Bonhoeffer S, Nowak MA (1996) Viral quasi-species and recombination. P R Soc Lond B Bio 263: 1577-1584.
24. Bretscher MT, Althaus CL, Muller V, Bonhoeffer S (2004) Recombination in HIV and the evolution of drug resistance: for better or for worse? Bioessays 26: 180-188.
25. Althaus CL, Bonhoeffer S (2005) Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1. J Virol 79: 13572-13578.
26. Bocharov G, Ford NJ, Edwards J, Breinig T, Wain-Hobson S, et al. (2005) A genetic-algorithm approach to simulating human immunodeficiency virus evolution reveals the strong impact of multiply infected cells and recombination. J Gen Virol 86: 3109-3118.
27. Fraser C (2005) HIV recombination: what is the impact on antiretroviral therapy? J R Soc Interface 2: 489-503.
28. Rouzine IM, Coffin JM (2005) Evolution of human immunodeficiency virus under election and weak recombination. Genetics 170: 7-18.
29. Carvajal-Rodriguez A, Crandall KA, Posada D (2007) Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy. Infect Genet Evol 7: 476-483.
30. Gheorghiu-Svirschevski S, Rouzine IM, Coffin JM (2007) Increasing sequence correlation limits the efficiency of recombination in a multisite evolution model. Mol Biol Evol 24: 574-586.
31. Suryavanshi GW, Dixit NM (2007) Emergence of recombinant forms of HIV: Dynamics and scaling. PLoS Comput Biol 3: e205.
32. Vijay NV, Vasantika, Ajmani R, Perelson AS, Dixit NM (2008) Recombination increases human immunodeficiency virus fitness, but not necessarily diversity. J Gen Virol 89: 1467-1477.
33. Arora P, Dixit NM (2009) Timing the emergence of resistance to anti-HIV drugs with large genetic barriers. PLoS Comput Biol 5: e1000305.
34. Gadhamsetty S, Dixit NM (2010) Estimating frequencies of minority nevirapineresistant strains in chronically HIV-1-infected individuals naive to nevirapine by using stochastic simulations and a mathematical model. J Virol 84: 10230-10240.
35. Rouzine IM, Coffin JM (2010) Multi-site adaptation in the presence of infrequent recombination. Theor Popul Biol 77: 189-204.
36. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, et al. (1999) Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73: 10489-10502.
37. Bonhoeffer S, Chappey C, Parkin NT, Whitcomb JM, Petropoulos CJ (2004) Evidence for positive epistasis in HIV-1. Science 306: 1547-1550.
38. Mansky LM, Temin HM (1995) Lower in-vivo mutation-rate of humanimmunodeficiency- virus type-1 than that predicted from the fidelity of purified reverse-transcriptase. J Virol 69: 5087-5094.
39. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. (2008) Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105: 7552-7557.
40. Goonetilleke N, Liu MKP, Salazar-Gonzalez JF, Ferrari G, Giorgi E, et al. (2009) The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 206: 1253-1272.
41. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, et al. (2009) Genetic identity, biological phenotype, and evolutionary pathways of transmitted/ founder viruses in acute and early HIV-1 infection. J Exp Med 206: 1273-1289.
42. Rhodes T, Wargo H, Hu W-S (2003) High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J Virol 77: 11193-11200.
43. Josefsson L, Brannstrom J, Makilato B, Maldarelli F, Kearney M, et al. (2010) Analysis of HIV DNA molecules in single infected cells from recently and chronically infected patients, Abstract #289. San Francisco: 17th Conference on Retroviruses and Opportunistic Infections.
44. Hockett RD, Michael Kilby J, Derdeyn CA, Saag MS, Sillers M, et al. (1999) Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med 189: 1545-1554.
45. Chen HY, Di Mascio M, Perelson AS, Ho DD, Zhang L (2007) Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proc Natl Acad Sci U S A 104: 19079-19084.
46. + cell turnover. Nature 375: 194-195.
47. Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, et al. (1993) Quantitation of human-immunodeficiency-virus type-1 infection kinetics. J Virol 67: 2182-2190.
48. Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, et al. (1993) High-levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259: 1749-1754.
49. Ribeiro RM, Qin L, Chavez LL, Li D, Self SG, et al. (2010) Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J Virol 84: 6096-6102.
50. Hill WG, Robertson A (1966) Effect of linkage on limits to artificial selection. Genet Res 8: 269-294.
51. Eshel I, Feldman MW (1970) On the evolutionary effect of recombination. Theor Popul Biol 1: 88-100.
52. Kouyos RD, Otto SP, Bonhoeffer S (2006) Effect of varying epistasis on the evolution of recombination. Genetics 173: 589-597.
53. Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16: 111-120.
54. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582-1586.
55. Dixit NM, Markowitz M, Ho DD, Perelson AS (2004) Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy. Antivir Ther 9: 237-246.
56. Voronin Y, Holte S, Overbaugh J, Emerman M (2009) Genetic drift of HIV populations in culture. PloS Genet 5: e1000431.
57. Gillespie JH (2000) Genetic drift in an infinite population: The pseudohitchhiking model. Genetics 155: 909-919.
58. Frost SDW, Dumaurier MJ, Wain-Hobson S, Brown AJL (2001) Genetic drift and within-host metapopulation dynamics of HIV-1 infection. Proc Natl Acad Sci U S A 98: 6975-6980.
59. Williamson S, Perry SM, Bustamante CD, Orive ME, Stearns MN, et al. (2005) A statistical characterization of consistent patterns of human immunodeficiency virus evolution within infected patients. Mol Biol Evol 22: 456-468.
60. Liu Y, Mullins JI, Mittler JE (2006) Waiting times for the appearance of cytotoxic T-lymphocyte escape mutants in chronic HIV-1 infection. Virology 347: 140-146.
61. Fellay J, Shianna KV, Ge DL, Colombo S, Ledergerber B, et al. (2007) A wholegenome association study of major determinants for host control of HIV-1. Science 317: 944-947.
62. Perelson AS (2002) Modelling viral and immune system dynamics. Nat Rev Immunol 2: 28-36.
63. Chen BK, Gandhi RT, Baltimore D (1996) CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J Virol 70: 6044-6053.
64. Piguet V, Gu F, Foti M, Demaurex N, Gruenberg J, et al. (1999) Nef-induced CD4 degradation: A diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 97: 63-73.
65. Dixit NM, Perelson AS (2005) HIV dynamics with multiple infections of target cells. Proc Natl Acad Sci U S A 102: 8198-8203.
66. Dang Q, Chen JB, Unutmaz D, Coffin JM, Pathak VK, et al. (2004) Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. Proc Natl Acad Sci U S A 101: 632-637.
67. Chen J, Dang Q, Unutmaz D, Pathak VK, Maldarelli F, et al. (2005) Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor. J Virol 79: 4140-4149.
68. Chen P, Hubner W, Spinelli MA, Chen BK (2007) Predominant Mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol 81: 12582-12595.
69. Dixit NM, Perelson AS (2004) Multiplicity of human immunodeficiency virus infections in lymphoid tissue. J Virol 78: 8942-8945.